Haleon, a global leader in trusted consumer health brands, released a report detailing its economic impact in Egypt during 2023, the first year of its market presence. Conducted by Oxford Economics, the study found that the company contributed 2.2 billion Egyptian pounds (approximately $72 million) to the country’s GDP. This figure includes direct, indirect, and induced effects stemming from Haleon’s operations. For every $100 spent by the company, an additional $4,400 was generated across the Egyptian economy, demonstrating a significant multiplier effect. The firm’s activities also supported 4,500 jobs nationwide, with each Haleon employee indirectly enabling 36.7 additional positions through supply chains and related services. Nearly all of Haleon’s procurement—98%—was sourced domestically, primarily covering operational expenses, while over 73% of purchases were allocated to locally manufactured goods. The company relied on 85 local suppliers to meet 96% of its needs, supplementing the remainder through international partners, thereby reinforcing Egypt’s supply chain networks. Dr. Ghada Noor, Assistant Minister of Investment and Foreign Trade, stated that Haleon’s investment reflects growing international confidence in Egypt’s business environment and supports high-value industrial development. Dr. Nahla Al-Subaie, Central Director of Decision Support at the Information and Decision Support Center, emphasized the role of such private-sector engagement in job creation and local manufacturing. Asif Alvi, General Manager for North Africa at Haleon, affirmed the company’s commitment to making self-care more accessible and integrated into daily Egyptian life, pledging continued innovation and local collaboration. Notably, Haleon exports its products from Egypt to select markets in North Africa, the Gulf, the Near East, and Saudi Arabia, reinforcing Egypt’s position as a regional hub for pharmaceutical and healthcare industries.
— news from áÙ Ù
ÙÙ
س
— News Original —
Report: Haleon supported the Egyptian economy with $72 million
Haleon, a global leader in trusted healthcare brands, issued a report on its economic impact in Egypt, prepared by Oxford Economics.
The report revealed that in 2023, the first year of the company’s presence in the Egyptian market, Haleon’s contribution to GDP reached 2.2 billion Egyptian pounds ($72 million). This included the direct, indirect, and catalytic impact of the company’s activities, with the report indicating that for every $100 spent by Haleon to support GDP, an additional $4,400 was generated in the Egyptian economy.
Haleon’s operations also enabled 4,500 new jobs nationwide, with every 10 Haleon employees indirectly supporting 367 additional jobs across supply chains and services linked to its activities.
The report noted that 98% of Haleon’s total purchases in the local market were operational expenses, compared to 2% capital expenditures, with over 73% going to locally manufactured products. The company relied on 85 local suppliers to cover 96% of its needs, with the remaining portion fulfilled by international suppliers, reflecting its role in activating Egypt’s supply chain and boosting indirect economic activity.
In this context, Dr. Ghada Noor, Assistant Minister of Investment and Foreign Trade, said: “Haleon’s strategic investments reflect growing international confidence in Egypt’s business environment. Their expansion supports our goals of attracting high-value industries, boosting local production, and increasing export capacity in the region.”
For her part, Dr. Nahla Al-Subaie, Central Director of Decision Support at the Information and Decision Support Center, stated: “Economic data clearly shows Haleon’s contribution to job creation and local investment in health products. Its presence in Egypt aligns with Egypt’s Vision 2030 and the state’s belief in the private sector’s role.”
Asif Alvi, General Manager for North Africa at Haleon, said: “Since our launch in Egypt in 2023, we have focused on making self-care more accessible, inclusive, and suited to Egyptians’ daily lifestyles. This report confirms the positive impact of our presence, not only as a company but as a committed partner in supporting healthy communities. We will continue expanding our contribution through meaningful innovation, strong local partnerships, and a deep understanding of Egyptian consumer needs.”
It is worth noting that Haleon produces and exports its brands from Egypt to selected markets in North Africa, the Gulf, the Near East, and Saudi Arabia, enhancing Egypt’s role as a regional center for pharmaceutical and healthcare industries.